[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2066753T3 - Uso de un preparado, que contiene inmunoglobulina, para la profilaxis y la terapia del sida, en personas. - Google Patents

Uso de un preparado, que contiene inmunoglobulina, para la profilaxis y la terapia del sida, en personas.

Info

Publication number
ES2066753T3
ES2066753T3 ES87101849T ES87101849T ES2066753T3 ES 2066753 T3 ES2066753 T3 ES 2066753T3 ES 87101849 T ES87101849 T ES 87101849T ES 87101849 T ES87101849 T ES 87101849T ES 2066753 T3 ES2066753 T3 ES 2066753T3
Authority
ES
Spain
Prior art keywords
preparation
prophylaxis
aids
therapy
people
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87101849T
Other languages
English (en)
Inventor
Hans Dipl Chem Dr Schleussner
Herbert Dr Dichtelmuller
Wolfgang Dipl Chem Dr Stephan
Reinhard Dipl Chem Dr Lissner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotest Pharma GmbH
Original Assignee
Biotest Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6294255&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2066753(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biotest Pharma GmbH filed Critical Biotest Pharma GmbH
Application granted granted Critical
Publication of ES2066753T3 publication Critical patent/ES2066753T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION SE REFIERE A UN PROCEDIMIENTO DE OBTENCION DE UN PREPARADO DE INMUNOGLOBULINAS PARA POFILAXIS Y TERAPIA DEL SIDA, POR ELABORACION A PARTIR DE SANGRE, PLASMA O SUERO DE UNA SOLUCION DE INMUNOGLOBULINAS Y POSTERIOR ESTERILIZACION Y EN ALGUNOS CASOS LIOFILIZACION. EN EL SE USA COMO MATERIAL DE PARTIDA SANGRE, PLASMA O SUERO ANTI HTLV-III/LAV-POSITIVO, POTENCIALMENTE INFECCIOSO Y A PARTIR DE ESTE PREPARADO QUE CONTIENE INMUNOGLOBULINAS SE ELABORA UN MEDICAMENTO PARA EL TRATAMIENTO TERAPEUTICO Y PROFILAXIS DEL SIDA.
ES87101849T 1986-02-17 1987-02-10 Uso de un preparado, que contiene inmunoglobulina, para la profilaxis y la terapia del sida, en personas. Expired - Lifetime ES2066753T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863604947 DE3604947A1 (de) 1986-02-17 1986-02-17 Verfahren zur herstellung eines immunglobulinhaltigen praeparates und dessen verwendung zur prophylaxe und therapie von aids

Publications (1)

Publication Number Publication Date
ES2066753T3 true ES2066753T3 (es) 1995-03-16

Family

ID=6294255

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87101849T Expired - Lifetime ES2066753T3 (es) 1986-02-17 1987-02-10 Uso de un preparado, que contiene inmunoglobulina, para la profilaxis y la terapia del sida, en personas.

Country Status (6)

Country Link
EP (1) EP0234405B1 (es)
JP (1) JPS62192326A (es)
AT (1) ATE115863T1 (es)
DE (2) DE3604947A1 (es)
ES (1) ES2066753T3 (es)
GR (1) GR3014952T3 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863730A (en) * 1986-03-21 1989-09-05 Cenfold Holdings, S.A. Immunotherapy for AIDS patients
DE3832578A1 (de) * 1987-09-29 1989-06-01 Spagyrik Heinz Inst Ag Arzneimittel zur bekaempfung der hiv-virus-infektion
JP2613409B2 (ja) * 1987-11-20 1997-05-28 株式会社ミドリ十字 抗エイズウイルス抗体陽性静注用免疫グロブリン製剤の製造方法
DE3825429C2 (de) * 1988-07-27 1994-02-10 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt
GB2225718A (en) * 1988-12-12 1990-06-13 Res & Education Inst Inc Kit and method for treatment of AIDS
FR2640511B1 (fr) * 1988-12-15 1993-04-23 Merieux Inst Medicaments pour le traitement ou la prevention par immunisation passive de l'infection par le virus hiv et procede de preparation
DE4041114C2 (de) * 1990-12-21 1994-02-17 Michael Dr Med Gruenspan Arzneimittel enthaltend eine IgG 2a-Antikörperfraktion aus Körperflüssigkeiten von HIV-infizierten Patienten
TW541179B (en) * 1997-03-19 2003-07-11 Green Cross Corp Process for preparing immunoglobulin preparation
KR20050095605A (ko) 2003-01-09 2005-09-29 제넨테크, 인크. 폴리펩티드의 정제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4102996A (en) * 1977-04-20 1978-07-25 Merck & Co., Inc. Method of preparing hepatitis B core antigen
JPS5848855A (ja) * 1981-09-17 1983-03-22 Green Cross Corp:The ＨＢｅ抗原の製法及びＨＢｅ抗体の検出試薬
US4863730A (en) * 1986-03-21 1989-09-05 Cenfold Holdings, S.A. Immunotherapy for AIDS patients

Also Published As

Publication number Publication date
JPS62192326A (ja) 1987-08-22
EP0234405B1 (de) 1994-12-21
DE3604947A1 (de) 1987-08-20
ATE115863T1 (de) 1995-01-15
DE3750886D1 (de) 1995-02-02
GR3014952T3 (en) 1995-05-31
DE3604947C2 (es) 1992-03-12
EP0234405A3 (en) 1989-03-15
EP0234405A2 (de) 1987-09-02

Similar Documents

Publication Publication Date Title
ES2109254T3 (es) Proteinas antigenas y vacunas que las contienen para la prevencion de cocidiosis.
ES554967A0 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
EP0199479A3 (en) Ozone decontamination of blood and blood products
ES2098029T3 (es) Vacunas de hepatitis que contienen monofosforil lipido a 3-o-desacilado.
DE3880766D1 (de) Konjugate von interferon alpha mit immunglobulinen.
ES2035384T3 (es) Procedimiento para la esterilizacion de sangre, plasma, derivados de la sangre y del plasma, suspensiones celulares o similares.
HU901585D0 (en) Method for treatment of viral infections using functional derivatives of icam-1
FI913943A0 (fi) Nya kroman- och tiokromanderivat.
ES2066753T3 (es) Uso de un preparado, que contiene inmunoglobulina, para la profilaxis y la terapia del sida, en personas.
ATE78696T1 (de) Arzneimittelzubereitung zur behandlung des immunmangels.
ES2040207T3 (es) Un procedimiento para preparar una sustancia antibiotica.
FR2491334B1 (es)
ES2088431T3 (es) Preparacion biologica y su utilizacion.
FR2458068B1 (es)
ATE108335T1 (de) Kit oder zusammensetzung zur vorbeugung oder behandlung von hiv-1 infektionen.
DE3874606D1 (de) Behandlung von viraler infektion.
FI881123A0 (fi) Inaktivering av human immunodeficiency virus (hiv) medelst fenol i proteinhaltiga loesningar.
ATE69549T1 (de) Erzeugnisse, enthaltend gallopamil und prazosin.
FI920934A0 (fi) Koostumus veriplasman stabiloimiseksi pastöroinnin aikana
DE69210737D1 (de) Verwendung von L-2-Oxothiazolidine-4-Carboxylate zur Herstellung eines Arzneimittels zur Behandlung von latenten HIV-Infektionen
ES2040362T3 (es) Procedimiento para la preparacion de 2-(benzhidrilsulfonil)acetamida.
DE3777196D1 (de) Anti-parathyroid-antikoerper-praeparat.
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов
MX9400210A (es) Tratamiento de infecciones virales.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 234405

Country of ref document: ES